First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
Christophe Le TourneauMassimo GhianiMaria Chiara CauRoberta DepenniGraziana RonzinoPierluigi BonomoVincenzo MontesarchioLuigi LeoJeltje SchultenSatu SalmioDiethelm MessingerAndrea SbranaEdith BorcomanMaria Grazia GhiPublished in: Cancer reports (Hoboken, N.J.) (2023)
EMR 062202-566.